Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 21:00 UTC |
Charney Laurence NDirector
|
SaleCommon Stock | 5,000 | $54.96 | $274,800.00 |
DisclosureSEC source: 0001437749-26-030343 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,640 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $54.92 to $54.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| August 07, 2026 Filed Aug 7, 2026 21:00 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-026608 · rdgdoc.xml · nonDerivative · entry 3 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,640 F1 · shares: 1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction. F2 · balance_after: 2. Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| August 07, 2026 Filed Aug 7, 2026 21:00 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-026608 · rdgdoc.xml · nonDerivative · entry 2 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,090 F1 · shares: 1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction. F2 · balance_after: 2. Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:00 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-026608 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,590 F1 · shares: 1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction. F2 · balance_after: 2. Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:03 UTC |
Lonial SagarDirector
|
GrantStock Tracking Unit · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-020679 · rdgdoc.xml · derivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:02 UTC |
HUME DANIELDirector
|
GrantStock Tracking Unit · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-020677 · rdgdoc.xml · derivative · entry 1 HUME DANIEL · CIK 0001645514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:02 UTC |
Hoberman KennethDirector
|
GrantStock Tracking Unit · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-020676 · rdgdoc.xml · derivative · entry 1 Hoberman Kenneth · CIK 0001573722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:01 UTC |
Echelard YannDirector
|
GrantStock Tracking Unit · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-020675 · rdgdoc.xml · derivative · entry 1 Echelard Yann · CIK 0001561958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:00 UTC |
Charney Laurence NDirector
|
GrantStock Tracking Unit · Derivative | 8,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-020673 · rdgdoc.xml · derivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 8,325 shares Expires not disclosed F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant. Read SEC document |
| January 29, 2026 Filed Jan 29, 2026 22:24 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 13,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002439 · rdgdoc.xml · nonDerivative · entry 2 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,690 F1 · shares: Represents a bona fide gift by the Reporting Person to the Reporting Person's children. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 28, 2026 Filed Jan 29, 2026 22:24 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002439 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,887 F1 · shares: Represents a bona fide gift by the Reporting Person to the Reporting Person's children. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 22:16 UTC |
WEISS MICHAEL SDirector · CEO
|
GrantCommon Stock | 622,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-001016 · rdgdoc.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,778,086 F1 · shares: Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 22:15 UTC |
Power Sean ACFO
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-001015 · rdgdoc.xml · nonDerivative · entry 1 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 798,111 F1 · shares: Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/27, 1/1/28, 1/1/29, and 1/1/30. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 22:31 UTC |
Echelard YannDirector
|
SaleCommon Stock | 5,000 | $32.57 | $162,850.00 |
DisclosureSEC source: 0001437749-25-036358 · rdgdoc.xml · nonDerivative · entry 1 Echelard Yann · CIK 0001561958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,816 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:01 UTC |
WEISS MICHAEL SDirector · CEO
|
GiftCommon Stock | 803,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033888 · rdgdoc.xml · nonDerivative · entry 2 WEISS MICHAEL S · CIK 0001038977 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,156,086 F3 · shares: Represents the transfer of shares to The Weiss Family and Descendants Trust. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:01 UTC |
WEISS MICHAEL SDirector · CEO
|
GiftCommon Stock | 3,865,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033888 · rdgdoc.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,959,803 F1 · shares: Represents distribution of shares upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:42 UTC |
Lonial SagarDirector
|
SaleCommon Stock | 20,852 | $32.24 | $672,268.48 |
DisclosureSEC source: 0001437749-25-028952 · rdgdoc.xml · nonDerivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,061 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy the Reporting Person's income tax obligations. F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $32.22 to $32.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 21:47 UTC |
Echelard YannDirector
|
SaleCommon Stock | 10,000 | $36.94 | $369,400.00 |
DisclosureSEC source: 0001437749-25-020546 · rdgdoc.xml · nonDerivative · entry 2 Echelard Yann · CIK 0001561958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,816 F3 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations. F4 · price: Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 21:45 UTC |
Lonial SagarDirector
|
GrantCommon Stock | 14,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020540 · rdgdoc.xml · nonDerivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,913 F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 21:47 UTC |
Echelard YannDirector
|
GrantCommon Stock | 14,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020546 · rdgdoc.xml · nonDerivative · entry 1 Echelard Yann · CIK 0001561958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,816 F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 21:47 UTC |
Charney Laurence NDirector
|
GrantCommon Stock | 21,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020545 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,887 F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 21:46 UTC |
Hoberman KennethDirector
|
GrantCommon Stock | 14,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020543 · rdgdoc.xml · nonDerivative · entry 1 Hoberman Kenneth · CIK 0001573722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,653 F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 21:45 UTC |
HUME DANIELDirector
|
GrantCommon Stock | 14,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020541 · rdgdoc.xml · nonDerivative · entry 1 HUME DANIEL · CIK 0001645514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,748 F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:01 UTC |
HUME DANIELDirector
|
GiftCommon Stock | 62,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-008284 · rdgdoc.xml · nonDerivative · entry 1 HUME DANIEL · CIK 0001645514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,030 F1 · shares: Reflects the transfer of shares of TG Therapeutics stock to a trust for the benefit of Mr. Hume's dependents. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 21:00 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007052 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,479 F1 · security: Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 22:17 UTC |
WEISS MICHAEL SDirector · CEO
|
GrantCommon Stock | 750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002292 · rdgdoc.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,824,929 F1 · shares: Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 22:15 UTC |
Power Sean ACFO
|
GrantCommon Stock | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002290 · rdgdoc.xml · nonDerivative · entry 1 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 708,111 F1 · shares: Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/26, 1/1/27, 1/1/28, and 1/1/29. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 23:01 UTC |
Power Sean ACFO
|
SaleCommon Stock | 10,021 | $28.53 | $285,939.21 |
DisclosureSEC source: 0001437749-25-000662 · rdgdoc.xml · nonDerivative · entry 2 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 660,611 F1 · shares: In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:01 UTC |
Power Sean ACFO
|
SaleCommon Stock | 11,337 | $30.29 | $343,443.08 |
DisclosureSEC source: 0001437749-25-000662 · rdgdoc.xml · nonDerivative · entry 1 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670,632 F1 · shares: In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 22:01 UTC |
Charney Laurence NDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-034595 · rdgdoc.xml · nonDerivative · entry 2 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,479 F3 · security: Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:02 UTC |
Lonial SagarDirector
|
SaleCommon Stock | 5,000 | $30.44 | $152,200.00 |
DisclosureSEC source: 0001437749-24-034597 · rdgdoc.xml · nonDerivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,195 F1 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:01 UTC |
Charney Laurence NDirector
|
SaleCommon Stock | 25,000 | $30.20 | $754,875.00 |
DisclosureSEC source: 0001437749-24-034595 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,479 F1 · price: Reflects the weighted average sale price. The range of prices for the shares sold was $30.17 to $30.29. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:35 UTC |
Echelard YannDirector
|
SaleCommon Stock | 20,000 | $24.48 | $489,600.00 |
DisclosureSEC source: 0001437749-24-033950 · rdgdoc.xml · nonDerivative · entry 1 Echelard Yann · CIK 0001561958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,098 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 20, 2024 Filed Jun 20, 2024 22:07 UTC |
Lonial SagarDirector
|
SaleCommon Stock | 16,348 | $16.87 | $275,790.76 |
DisclosureSEC source: 0001437749-24-020851 · rdgdoc.xml · nonDerivative · entry 3 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,195 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 19, 2024 Filed Jun 20, 2024 22:07 UTC |
Lonial SagarDirector
|
GrantCommon Stock | 22,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020851 · rdgdoc.xml · nonDerivative · entry 2 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,543 F3 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 19, 2024 Filed Jun 20, 2024 22:07 UTC |
HUME DANIELDirector
|
GrantCommon Stock | 22,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020850 · rdgdoc.xml · nonDerivative · entry 1 HUME DANIEL · CIK 0001645514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,489 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 19, 2024 Filed Jun 20, 2024 22:05 UTC |
Hoberman KennethDirector
|
GrantCommon Stock | 22,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020849 · rdgdoc.xml · nonDerivative · entry 1 Hoberman Kenneth · CIK 0001573722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,935 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 19, 2024 Filed Jun 20, 2024 22:05 UTC |
Echelard YannDirector
|
GrantCommon Stock | 22,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020848 · rdgdoc.xml · nonDerivative · entry 1 Echelard Yann · CIK 0001561958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,098 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 19, 2024 Filed Jun 20, 2024 22:04 UTC |
Charney Laurence NDirector
|
GrantCommon Stock | 22,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020847 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,479 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 22:07 UTC |
Lonial SagarDirector
|
SaleCommon Stock | 9,585 | $16.39 | $157,098.15 |
DisclosureSEC source: 0001437749-24-020851 · rdgdoc.xml · nonDerivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,293 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:37 UTC |
Lonial SagarDirector
|
SaleCommon Stock | 5,000 | $15.94 | $79,675.00 |
DisclosureSEC source: 0001437749-24-008124 · rdgdoc.xml · nonDerivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,878 F1 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:52 UTC |
Charney Laurence NDirector
|
SaleCommon Stock | 22,000 | $15.97 | $351,340.00 |
DisclosureSEC source: 0001437749-24-007662 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,229 F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. F2 · price: Reflects the weighted average sale price. The range of prices for the shares sold was $15.95 to $16.00. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 06, 2024 Filed Jan 8, 2024 23:32 UTC | GrantCommon Stock | 1,001,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000899 · rdgdoc.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,074,929 F1 · shares: Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
|
| January 05, 2024 Filed Jan 5, 2024 22:00 UTC |
Power Sean ACFO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000756 · rdgdoc.xml · nonDerivative · entry 2 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 681,969 F3 · shares: Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 23:33 UTC |
Charney Laurence NDirector
|
SaleCommon Stock | 17,500 | $19.03 | $333,025.00 |
DisclosureSEC source: 0001437749-24-000900 · rdgdoc.xml · nonDerivative · entry 1 Charney Laurence N · CIK 0001407451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,229 F1 · shares: In connection with the vesting of 58,732 shares on January 4, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. Mr. Charney had no discretion with respect to such sale, which was transacted in accordance with the Company's corporate policies regarding the vesting of restricted stock. F2 · price: Reflects the weighted average sale price. The range of prices for the shares sold was $19.01 to $19.06. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:00 UTC |
Power Sean ACFO
|
SaleCommon Stock | 47,867 | $16.91 | $809,430.97 |
DisclosureSEC source: 0001437749-24-000756 · rdgdoc.xml · nonDerivative · entry 1 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 606,969 F1 · shares: In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| December 15, 2023 Filed Feb 15, 2024 02:53 UTC |
Power Sean ACFO
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004259 · rdgdoc.xml · nonDerivative · entry 1 Power Sean A · CIK 0001538845 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 641,969 F1 · security: Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust. Read SEC document |
| September 28, 2023 Filed Sep 29, 2023 21:02 UTC |
Lonial SagarDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-105403 · tm2327273-5_4seq1.xml · nonDerivative · entry 1 Lonial Sagar · CIK 0001816609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,878 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2024. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| September 28, 2023 Filed Sep 29, 2023 21:01 UTC |
HUME DANIELDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-105400 · tm2327273-4_4seq1.xml · nonDerivative · entry 1 HUME DANIEL · CIK 0001645514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,239 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2024. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
| September 28, 2023 Filed Sep 29, 2023 21:01 UTC |
Hoberman KennethDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-105394 · tm2327273-3_4seq1.xml · nonDerivative · entry 1 Hoberman Kenneth · CIK 0001573722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,685 F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2024. F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.